Phase I study of the safety and clinical activity of the interleukin-8 inhibitor AMY109 combined with atezolizumab in patients with advanced solid cancers
==========================================================================================================================================================

* Noboru Yamamoto
* Shigehisa Kitano
* Takafumi Koyama
* Masafumi Ikeda
* Hidenori Mizugaki
* Takatsugu Narikiyo
* Yuki Yamaguchi
* Takaaki Ishida
* Ryoko Takubo
* Chika Ogami
* Mayuko Sekiya
* Yuki Nakagawa
* Yasutoshi Kuboki